OssDsign AB Logo

OssDsign AB

Developer of orthobiologics for bone regeneration in spinal fusion surgery.

OSSD | ST

Overview

Corporate Details

ISIN(s):
SE0012570448
LEI:
5493005SNS5NAYE2WL53
Country:
Sweden
Address:
Ulls väg 29C, 756 51 Uppsala

Description

OssDsign is a developer and global provider of next-generation orthobiologics products based on advanced material science. The company develops and markets products that support the body's own healing capabilities, with a primary focus on bone regeneration for spinal fusion surgery. Its flagship product, OssDsign Catalyst®, is a nanosynthetic bone graft putty engineered to engage dual bone formation pathways, promoting rapid and reliable bone formation. OssDsign Catalyst® is the first synthetic bone graft to receive clearance for on-label interbody use based on bone graft data alone, allowing it to be used in any interbody cage cleared for use with synthetic bone grafts. This unique regulatory status, combined with its handling characteristics, differentiates the product in the orthobiologics market.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all OssDsign AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for OssDsign AB

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for OssDsign AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

BIO-FD&C CO.,LTD. Logo
Develops active ingredients for cosmetics and pharma using a plant cell platform technology.
South Korea
251120
Biofrontera AG Logo
Biopharmaceutical firm specializing in photodynamic therapy for skin conditions.
Germany
B8F
Biofrontera Inc. Logo
A biopharmaceutical company commercializing products for dermatological conditions.
United States of America
BFRI
BioGaia Logo
A healthcare and biotechnology company developing clinically proven probiotic products.
Sweden
BIOG
BIOGEN INC. Logo
Biotechnology company developing therapies for neurological and neurodegenerative diseases.
United States of America
BIIB
Bio Green Med Solution, Inc. Logo
A diversified company in the biopharmaceutical and fire safety sectors.
United States of America
BGMS
BIOHARVEST SCIENCES INC. Logo
A biotech firm using a platform to grow plant cells for health and wellness products.
United States of America
BHST
Biohaven Ltd. Logo
Develops therapies for neuroscience, immunology, and oncology for unmet medical needs.
United States of America
BHVN
BioInvent International Logo
Develops novel, first-in-class immuno-modulatory antibodies for cancer therapy.
Sweden
BINV
BIOLIFE SOLUTIONS INC Logo
Manufactures biopreservation media and tools for cell and gene therapy markets.
United States of America
BLFS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.